138 related articles for article (PubMed ID: 7655331)
1. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
2. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
Kilias D; Macrae FA; Sharpe K; Young GP
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
[TBL] [Abstract][Full Text] [Related]
3. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological use of rectal proliferation measures.
Baron JA; Wargovich MJ; Tosteson TD; Sandler R; Haile R; Summers R; van Stolk R; Rothstein R; Weiss J
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):57-61. PubMed ID: 7894325
[TBL] [Abstract][Full Text] [Related]
5. Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations.
Sawtell RM; Rew DA; Stradling RN; Wilson GD
Cytometry; 1995 Sep; 22(3):190-9. PubMed ID: 8556950
[TBL] [Abstract][Full Text] [Related]
6. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
Krishnan K; Aoki T; Ruffin MT; Normolle DP; Boland CR; Brenner DE
Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
[TBL] [Abstract][Full Text] [Related]
7. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
McShane LM; Kulldorff M; Wargovich MJ; Woods C; Purewal M; Freedman LS; Corle DK; Burt RW; Mateski DJ; Lawson M; Lanza E; O'Brien B; Lake W; Moler J; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
[TBL] [Abstract][Full Text] [Related]
9. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
[TBL] [Abstract][Full Text] [Related]
10. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
Murray SC; Sandler RS; Keku TO; Lyles CM; Millikan RC; Bangdiwala SI; Kupper LL; Jiang W; Ulshen MH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):715-20. PubMed ID: 8672987
[TBL] [Abstract][Full Text] [Related]
11. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
[TBL] [Abstract][Full Text] [Related]
12. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
14. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
Keku TO; Galanko JA; Murray SC; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
Zeymer U; Fishbein MC; Forrester JS; Cercek B
Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299
[TBL] [Abstract][Full Text] [Related]
17. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
[TBL] [Abstract][Full Text] [Related]
18. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
20. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]